Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;34(5):237.e19-26.
doi: 10.1016/j.urolonc.2015.11.020. Epub 2015 Dec 18.

Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy

Leonardo D Borregales  1 , Dae Y Kim  1 , Angie L Staller  1 , Wei Qiao  2 , Arun Z Thomas  1 , Mehrad Adibi  1 , Pheroze Tamboli  3 , Kanishka Sircar  3 , Eric Jonasch  4 , Nizar M Tannir  4 , Surena F Matin  1 , Christopher G Wood  1 , Jose A Karam  5
Affiliations

Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy

Leonardo D Borregales et al. Urol Oncol. 2016 May.

Abstract

Objective: To study the natural history, prognosticators, and outcomes in patients with renal cell carcinoma (RCC) with extension of tumor beyond Gerota׳s fascia or invading contiguously into the adrenal gland (pT4) or both.

Patients and methods: From 1992 to 2012, we identified 61 patients who underwent radical nephrectomy and were found to have pT4 disease. Clinicopathologic variables were queried using univariate analysis to identify relevant prognostic variables. Cox proportional hazards model was used for multivariate analysis of predictors of cancer-specific survival. Survival plots were estimated using Kaplan-Meier method and survival analysis using log-rank test.

Results: Median age was 56 years (interquartile range: 49-64) and 49 (81.7%) patients had Eastern Cooperative Oncology Group Performance Status 0 or 1. At diagnosis, 22 (36.1%) patients showed nonmetastatic and 39 (63.9%) patients showed metastatic RCC. Overall, 49 (80.3%) patients had clear cell RCC, 24 (39.3%) patients had sarcomatoid features, and 39 (69.6%) patients had Fuhrman grade 3 to 4. There were 26 (42.6%) patients with pN0, 16 (26.2%) patients with pN1, and 19 (31.1%) patients with pNx. Median cancer-specific survival was 37 months for patients with nonmetastatic and 8 months for patients with metastatic RCC. On multivariate analysis, preoperative lactate dehydrogenase and alkaline phosphatase, M stage, pN stage, and sarcomatoid dedifferentiation were significantly associated with survival.

Conclusions: Survival in patients with pT4 remains poor. The pT4 disease is associated with a locally and regionally invasive biology that requires specific attention and warrants careful study. Understanding the drivers of this unique phenotype would generate therapeutic interventions that can change the behavior of these uniquely aggressive tumors.

Keywords: Nephrectomy; Predictors; Renal cell carcinoma; Surgery; T4.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cancer-specific survival stratified by M stage. (Log rank p<0.01).
Figure 2
Figure 2
Cancer-specific survival stratified by presence of sarcomatoid features. (Log rank p<0.01).
Figure 3
Figure 3
Cancer-specific survival stratified by pathological nodal status. (Log rank p<0.01).
Figure 4
Figure 4
Cancer-specific survival stratified by adrenal involvement. (Log rank p=0.57).
Figure 5
Figure 5
Cancer-specific survival stratified by presence of systemic symptoms at time of diagnosis. (Log rank p= 0.01).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
    1. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113:78–83. - PubMed
    1. Lam JS, Belldegrun AS, Pantuck AJ. Long-term outcomes of the surgical management of renal cell carcinoma. World journal of urology. 2006;24:255–66. - PubMed
    1. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. The Journal of urology. 2002;168:2395–400. - PubMed
    1. Kim SP, Alt AL, Weight CJ, Costello BA, Cheville JC, Lohse C, et al. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. The Journal of urology. 2011;185:2035–9. - PubMed

Publication types